HRA007457
Title:
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma
Release date:
2024-05-31
Description:
we conducted a retrospective evaluation of one hundred newly diagnosed DLBCL patients as a training cohort and subsequently recruited an additional twenty-six newly diagnosed DLBCL patients for validation to reveal the clinical and biological implications of CSF ctDNA positivity in newly diagnosed DLBCL patients
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
non-Hodgkin lymphoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
DLBCL CSF-ctDNA
Contact person:
Wu Yifan
Email:
nmuwyf9999@163.com
Description:
DAC is responsible for all data management of the DLBCL CSF-ctDNA project
Individuals & samples
Submitter:   Xu Wei / xuwei10000@hotmail.com
Organization:   The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Submission date:   2024-05-20
Requests:   -